Business ❯ Pharmaceutical Industry

Generic Drugs

Market Access Market Competition Market Regulation Market Dynamics Market Trends Market Impact Manufacturing Drug Pricing Market Approval Amneal Pharmaceuticals

FDA Clears First Generic Flovent HFA Inhaler as Glenmark Prepares U.S. Launch

The approval targets better access at lower cost after GSK's 2024 withdrawal.

Canada Opens Path to Generic Ozempic as Health Canada Weighs Nine Applications

Brazil’s Superior Court of Justice Rejects Semaglutide Patent Extension, Paving Way for 2026 Generics

Hawley Pressures FDA Chief as Anti‑Abortion Groups Demand Firing Over Reported Mifepristone Review Delay

Gilead Starts Shipping Twice-Yearly HIV Prevention Shot to Eswatini and Zambia

FDA Proposes Faster Biosimilar Approvals by Dropping Routine Human Trials

California Sets Jan. 1, 2026 Launch for $11 CalRx Insulin Pens

South Africa Sets April 2026 Rollout for Twice-Yearly HIV-Prevention Shot, With Limited Early Supply

India Cough Syrup Crisis: Sresan Pharma Owner Detained as Tamil Nadu Confirms Toxic Contamination

France Restores 40% Cap on Generic-Drug Rebates Through Year-End After Pharmacists’ Protests

Deals Set $40 Generics of Twice-Yearly HIV Prevention Shot for 120 Countries by 2027

France Pauses Generic Discount Cuts for Three Months After Pharmacy Protests

Nearly One in Five India-Made Chemotherapy Drugs Fall Short in Global Tests

Trump Administration’s Planned 25% Tariffs on Pharmaceuticals Expected to Raise U.S. Drug Costs by $51 Billion Annually

California Expands Access to Affordable Naloxone for Residents

EU Fines Teva $503 Million for Blocking MS Drug Competition

Teva Pharmaceuticals Settles $450M Kickback and Price-Fixing Allegations